Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom

被引：107
|
作者：
Threlfall, EJ [1 ]
Ward, LR [1 ]
机构：
[1] Cent Publ Hlth Lab, Lab Enter Pathogens, London NW9 5HT, England
来源：
EMERGING INFECTIOUS DISEASES | 2001年 / 7卷 / 03期
关键词：
D O I：
10.3201/eid0703.017315
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
In 1999, 23% of Salmonella enterica serotype Typhi isolates from patients in the United Kingdom exhibited decreased susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/L); more than half were also resistant to chloramphenicol, ampicillin, and trimethoprim. Increasing numbers of treatment failures have been noted. Most infections have been in patients with a recent history of travel to India and Pakistan.
引用
收藏
页码：448 / 450
页数：3
相关论文
共 50 条
  • [31] Antimicrobial resistance of Salmonella enterica serotype typhi in Dakar, Senegal
    Dromigny, JA
    Perrier-Gros-Claude, JD
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (03) : 465 - 466
  • [32] Bilateral Breast Abscesses due to Salmonella Enterica Serotype Typhi
    Singh, Gagandeep
    Dasgupta, Mahua
    Gautam, Vikas
    Behera, Arunanshu
    Ray, Pallab
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2011, 3 (04) : 402 - 404
  • [33] Salmonella enterica Serotype Typhi with Nonclassical Quinolone Resistance Phenotype
    Accou-Demartin, Marie
    Gaborieau, Valerie
    Song, Yajun
    Roumagnac, Philippe
    Marchou, Bruno
    Achtman, Mark
    Weill, Francois-Xavier
    EMERGING INFECTIOUS DISEASES, 2011, 17 (06) : 1091 - 1094
  • [34] Emerging resistance in Salmonella enterica serotype Typhi in Hong Kong
    Ling, JM
    Lo, NWS
    Ho, YM
    Kam, KM
    Ma, CH
    Wong, SC
    Cheng, AF
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1996, 7 (03) : 161 - 166
  • [35] In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi
    Kim, Dong-Min
    Neupane, Ganesh Prasad
    Jang, Sook Jin
    Kim, Sung Hun
    Lee, Bok Kwon
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (02) : 155 - 158
  • [36] Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae
    Crump, JA
    Barrett, TJ
    Nelson, JT
    Angulo, FJ
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (01) : 75 - 81
  • [37] Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya
    Mutai, Winnie C.
    Muigai, Anne W. T.
    Waiyaki, Peter
    Kariuki, Samuel
    BMC MICROBIOLOGY, 2018, 18
  • [38] Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya
    Winnie C. Mutai
    Anne W. T. Muigai
    Peter Waiyaki
    Samuel Kariuki
    BMC Microbiology, 18
  • [39] Ciprofloxacin-resistant Salmonella enterica serotype Typhimurium, China
    Cui, Shenghui
    Li, Jingyun
    Sun, Ziyong
    Hu, Changqin
    Jin, Shaohong
    Guo, Yunchang
    Ran, Lu
    Ma, Yue
    EMERGING INFECTIOUS DISEASES, 2008, 14 (03) : 493 - 495
  • [40] Intermediate Susceptibility to Ciprofloxacin in Salmonella typhi Strains in India
    G. Mehta
    V. S. Randhawa
    N. P. Mohapatra
    European Journal of Clinical Microbiology and Infectious Diseases, 2001, 20 : 760 - 761
12345